Features of Prescribing Modern Sugar-Lowering Drugs to Patients with Type 2 Diabetes Mellitus

The number of patients with type 2 diabetes mellitus (DM2) is steadily increasing. According to Diabetes Atlas 2021, there are 536 million people with type 2 diabetes worldwide. At the same time, experts say that the number of undiagnosed diabetes mellitus (DM) may exceed the level recorded today by 2-3 times. Therefore, rational pharmacotherapy of this disease is the subject of numerous scientific and clinical studies. One of the largest recent studies has been the UK Diabetes Control and Complications Prospective Study (UKPDS). It lasted for about 20 years more than 5000 patients with type 2 diabetes participated in it. Patients were divided into groups who received different types of treatment since the moment of DM detection: only diet, various oral hypoglycemic drugs, insulin therapy